Clinical Trial Update: Outcome-related Factors in Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus (ORCHIDEE) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing outcome-related factors in patients with metastatic renal cell carcinoma treated with everolimus has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Renal Cell Carcinoma | Phase 4 | Status: TERMINATED